C86.4

Clinical Causes: Genetic mutations affecting NK-cell development and function Oncogenic transformation of plasmacytoid dendritic cells Potential role of environmental factors, although specific causes remain under research

Key Symptoms: Swollen lymph nodes, often painless and enlarged B symptoms such as fever, night sweats, and unexplained weight loss Skin lesions or rashes, sometimes mistaken for infections or skin conditions Fatigue or weakness Frequent infections due to compromised immune function Bleeding or easy bruising in some cases

Diagnosis Path: Diagnosing blastic NK-cell lymphoma typically involves a combination of clinical evaluation, imaging studies, and laboratory tests. A biopsy of affected lymph nodes or skin lesions reveals the presence of malignant NK or plasmacytoid dendritic cells. Immunophenotyping via immunohistochemistry helps identify specific markers characteristic of these malignant cells. Additional tests such as flow cytometry, molecular genetic testing, and imaging scans (like PET or CT) assist in staging and confirming the diagnosis.

Treatment Protocols: Treating blastic NK-cell lymphoma usually involves intensive chemotherapy regimens similar to those used for other rapidly progressing lymphomas. Due to its aggressive course, stem cell transplantation may be considered for eligible patients to improve outcomes. Supportive care includes managing symptoms and preventing infections. Emerging targeted therapies and immunotherapies are under investigation and may offer future options. Because of the complexity and rarity of this condition, treatment is personalized and typically coordinated by a team of specialists experienced in lymphoma management.